Nitric oxide reduces nontransferrin-bound iron transport in HepG2 cells.

Barisani, D; Cairo, G; Ginelli, E; Marozzi, A; Conte, D

Barisani, D; Cairo, G; Ginelli, E; Marozzi, A; Conte, D.

Affiliation

Barisani D; Cattedra di Gastroenterologia, Istituto di Scienze Mediche, Istituto di Ricovero e Cura a Carattere Scientifico, Ospedale Maggiore, Milan, Italy. dibiogen@imiucca.csi.unimi.it

Hepatology ; 29(2): 464-70, 1999 Feb.

Article in En | MEDLINE | ID: mdl-9918923

Subject(s)

Carcinoma, Hepatocellular/metabolism; Iron/metabolism; Liver Neoplasms/metabolism; Nitric Oxide Donors/pharmacology; Nitric Oxide/pharmacology; Transferrin/metabolism; Apoptosis; Biological Transport/drug effects; Ferric Compounds/metabolism; Ferritins/genetics; Ferrous Compounds/metabolism; Humans; Kinetics; Nitroprusside/pharmacology; Penicillamine/analogs & derivatives; Penicillamine/pharmacology; RNA, Messenger/metabolism; Receptors, Transferrin/genetics; Tumor Cells, Cultured

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Transferrin / Carcinoma, Hepatocellular / Nitric Oxide Donors / Iron / Liver Neoplasms / Nitric Oxide Limits: Humans Language: En Journal: Hepatology Year: 1999 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links